Zydus Healthcare Ltd., based in Mumbai, is a leading pharmaceutical manufacturer in India, excelling in both acute and chronic therapies. The company, with a rich history, holds leadership positions in various therapeutic categories, showcasing unwavering dedication to excellence.
Zydus Healthcare has pioneered diabetes solutions with Lipaglyn, a groundbreaking therapy. Additionally, Zydus Biologics, under Zydus Lifesciences Ltd., is a key player in biologics, focusing on oncology, hepatology, nephrology, rheumatology, ophthalmology, and bone health.
Zydus Biologics covers drug development, manufacturing, distribution, and commercialization, emphasizing diverse and advanced healthcare solutions, including biosimilars like Exemptia and initiatives like Vaxiflu S, Vaxiflu 4, and ZyVac TCV.
In vaccines and diagnostics, Zydus Biologics addresses unmet healthcare needs, aligning with Zydus Cadila’s commitment to public health.
Zydus Cadila’s India Business embodies excellence, innovation, and improved healthcare accessibility, making it a trailblazer in the Indian pharmaceutical industry. The company’s impact on healthcare in India and beyond is set to grow as it continues to forge new paths in research and development.